Zimmer Biomet to Present at Stifel's 2021 Virtual Healthcare Conference

Go back to Zimmer Biomet to Present at Stifel's 2021 Virtual Healthcare Conference

Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities

November 4, 2021 6:09 PM EDT

Truist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.

The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More

Zimmer Biomet (ZBH) PT Lowered to $175 at Needham & Company

November 4, 2021 1:45 PM EDT

Needham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $187.00) while maintaining a Strong Buy rating.

The analyst commented, "ZBH's 3Q21 revenue missed while EPS beat consensus. Growth slowed due to procedure disruption and a tougher comp... More